Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says

People who took Pfizer's antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn't, the study said.

Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says
People who took Pfizer's antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn't, the study said.